NEW BRAVECTO® PLUS (fluralaner and moxidectin topical solution) for Cats is the solution for fleas, ticks, heartworm and intestinal parasites in ONE easy, 2-month topical. Specifically designed for the challenges of treating cats, BRAVECTO PLUS delivers everything that you expect from BRAVECTO and more.
BRAVECTO PLUS is indicated for the prevention of heartworm disease caused by Dirofilaria immitis and for the treatment of infections with intestinal roundworm (Toxocara cati; 4th stage larvae, immature adults and adults) and hookworm (Ancylostoma tubaeforme; 4th stage larvae, immature adults and adults). BRAVECTO PLUS kills adult fleas and is indicated for the treatment and prevention of flea infestations (Ctenocephalides felis) and the treatment and control of tick infestations [Ixodes scapularis (black-legged tick) and Dermacentor variabilis (American dog tick)] for 2 months in cats and kittens 6 months of age and older and weighing 2.6 lb or greater.
One application/tube per weight band
Extended duration = protection against fleas
The 2-month efficacy of a single dose of BRAVECTO PLUS against Ctenocephalides felis fleas has been confirmed in laboratory studies.1
Residual speed of kill and persistent efficacy against fleas (C. felis)1
Efficacy against fleas was 100% within 12 hours and > 99% for 2 months.1
Extended duration = protection against ticks
Efficacy against ticks (Ixodes scapularis and Dermacentor variabilis)2
Broad spectrum = prevents heartworm disease
Innovative approach to heartworm (Dirofilaria immitis) disease prevention3
BRAVECTO PLUS was 100% effective against heartworm disease for 2 months. Uniquely, in the studies, the cats were treated 60 days before 3rd stage larval infection, thereby proactively protecting the cats.3
Broad spectrum = treatment of roundworms
Efficacy against roundworms (Toxocara cati) for 2 months4
In well-controlled laboratory studies, BRAVECTO PLUS was effective against naturally and experimentally induced adult and experimentally induced 4th stage larval and immature adult Toxocara cati infection in cats.5
Broad spectrum = treatment of hookworms
Efficacy against hookworms (Ancylostoma tubaeforme) for 2 months6
In well-controlled laboratory studies, BRAVECTO PLUS was effective against naturally and experimentally induced adult and experimentally induced 4th stage larval and immature adult Ancylostoma caninum infection in cats.5
No items to show.
Recommend the feline flea and tick topical that is indicated for internal and external parasites, and lasts twice as long as monthly products.
Fewer Doses. Less Stress.
You know that cats can be difficult when it comes to treatments and medications. BRAVECTO PLUS for Cats can help. A 2-month (vs. monthly) flea and tick protection plus treatment for intestinal parasites and heartworm prevention can be easier on cat owners because it requires less frequent dosing. And, an extended duration product can help encourage compliance.7-9
BRAVECTO PLUS Benefits Cat Owners and Your Clinic.
Easy for Cat Owners
A 2-month topical that combines flea and tick protection, treatment of intestinal parasites, and heartworm prevention can be easier on cat owners than monthly doses of multiple products.
Creates Less Stress
An extended duration product can help ease the stress on cats and their owners.
Less frequent application may lead to fewer gaps in protection.7-9
Increases Length of Protection
Using a 2-month product can increase the overall number of months of coverage.7-9
Fits Scientific Recommendations
The Companion Animal Parasite Council (CAPC) recommends year-round protection in cats against fleas, ticks, heartworm, roundworms, and hookworms.10
BRAVECTO PLUS Available Resources
A comprehensive guide to the benefits of BRAVECTO PLUS, including studies and application instructions.
IMPORTANT SAFETY INFORMATION The most commonly reported adverse reactions include vomiting, hair loss, itching, diarrhea, lethargy, dry skin, elevated ALT, and hypersalivation. BRAVECTO PLUS has not been shown to be effective for 2 months in kittens less than 6 months of age. For topical use only. Avoid oral ingestion. The safety of BRAVECTO PLUS has not been established in breeding, pregnant and lactating cats. Fluralaner is a member of the isoxazoline class. This class has been associated with neurologic adverse reactions including tremors, ataxia, and seizures. Neurologic adverse reactions have been reported in cats receiving isoxazoline class drugs, even in cats without a history of neurologic disorders. Use with caution in cats with a history of neurologic disorders. Use with caution in cats that are heartworm positive. The effectiveness of BRAVECTO PLUS to prevent heartworm disease after bathing or water immersion has not been evaluated.
1. BRAVECTO PLUS FOI, NADA 141-518. (Study S15318-00). 2. BRAVECTO PLUS FOI, NADA 141-518. (Studies S15312-03, 15311-01). 3. BRAVECTO PLUS FOI, NADA 141-518. (Studies S15102-01, S15102-03). 4. BRAVECTO PLUS FOI, NADA 141-518. (Studies S15214-02, S15313-00, S15356-00, S15187-00). 5. BRAVECTO PLUS [prescribing information]. Madison, NJ: Intervet Inc. (d/b/a Merck Animal Health); 2019. 6. BRAVECTO PLUS FOI, NADA 141-518. (Studies S15138-00, S15214-02, S15313-00, S15355-00). 7. Lavan RP et al. Parasites & Vectors. 2017; 10:284. 8. Lavan RP et al. Parasites & Vectors. 2018; 11:581. 9. Brakke Consulting. The US Flea Control and Heartworm Markets. 2018:6-7. 10. CAPC website. Intestinal Parasite Guidelines. Found at www.capcvet.org. Accessed July 11, 2019.
Revolution PLUS is a registered trademark of Zoetis Services LLC.